Agyeman PK, Schlapbach LJ, Giannoni E, Stocker M, Posfay-Barbe KM, Heininger U, et al. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study. Lancet. 2017;1:124–33.
Weiss, Fitzgerald SL, Pappachan JC, Wheeler J, Jaramillo-Bustamante D, Salloo JC, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191:1147–57.
Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis. Pediatr Crit Care Med. 2013;14:686–93.
Jaramillo-Bustamante JC, Marín-Agudelo A, Fernández-Laverde M, Bareño-Silva J. Epidemiology of sepsis in pediatric intensive care units: first Colombian multicenter study. Pediatr Crit Care Med. 2012;13:501–8.
Wolfler A, Silvani P, Musicco M, Antonelli M, Salvo I. Italian Pediatric Sepsis Study (SISPe) group. Incidence of and mortality due to sepsis, severe sepsis and septic shock in Italian Pediatric Intensive Care Units: a prospective national survey. J Intensive Care Med 2008;34:1690–7.
Khilnani P, Sarma D, Zimmerman J. Epidemiology and peculiarities of pediatric multiple organ dysfunction syndrome in New Delhi, India. J Intensive Care Med 2006;32:1856–62.
Inwald DP, Tasker RC, Peters MJ, Nadel S. Emergency management of children with severe sepsis in the United Kingdom: the results of the Paediatric Intensive Care Society sepsis audit. Arch Dis Child Educ Pr Ed. 2009;94:348–53.
Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME, et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. J Pediatr. 2003;112:793–9.
Wynn JL, Wong HR. Pathophysiology and treatment of septic shock in neonates. Clin Perinato. 2010;37:439–79.
Wilson W, Lipman J, Scribante J, Kobilski S, Lee C, Krause P, et al. Septic shock: does epinephrine have a role as a first-line inotropic agent? Anaesth Intensive Care. 1992;20:470–4.
Seri I. Cardiovascular, renal, and endocrine actions of dopamine in neonates and children. J Pediatr. 1995;126:333–44.
Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2–8.
Galletta F, Cucinotta U, Gambadauro A, Marseglia L, Cannavo L, Cuppari C, et al. Recent recommendations of neonatal septic shock: a review article. J Biol Regul Homeost Agents. 2022;36:107–15.
Ramaswamy KN, Singhi S, Jayashree M, Bansal A, Nallasamy K. Double-blind randomized clinical trial comparing dopamine and epinephrine in pediatric fluid-refractory hypotensive septic shock. Pediatr Crit Care Med. 2016;17:e502–12.
Baske K, Saini SS, Dutta S, Sundaram V. Epinephrine versus dopamine in neonatal septic shock: a double-blind randomized controlled trial. Eur J Pediatr. 2018;177:1335–42.
Valverde E, Pellicer A, Madero R, Elorza D, Quero J, Cabañas F. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes. J Pediatr. 2006;117:1213–22.
Ventura AM, Shieh HH, Bousso A, Góes PF, de Iracema Cássia FO, et al. Double-blind prospective randomized controlled trial of dopamine versus epinephrine as first-line vasoactive drugs in pediatric septic shock. Crit Care Med. 2015;43:2292–302.
Phillipos EZ, Barrington KJ, Robertson MA. Dopamine (D) versus epinephrine (E) for inotropic support in the neonate: a randomized double blinded controlled trial. Pediatr Res. 1996;39:238.
